MADRID, Fabrairu 1, 2022 / PRNewswire/ - Tsohuwar Tafarnuwa Baƙar fata (ABG +®), samfurin fasahar kere kere na harhada magunguna, SLU, ya nuna sabon yuwuwar fa'ida don daidaita hawan jini a cikin sabon binciken asibiti a cikin mutanen da ke da matsakaicin matsakaicin matakan cholesterol.ABG+ ana noma shi a cikin gida kuma ana noma shi, sa'o'i biyu kacal daga wurin samar da magunguna, kuma ana sarrafa shi a hankali ta amfani da fasahohin da ba su dace da muhalli ba.Wannan tsari yana haifar da sharar gida kaɗan kuma yana rage tasirin muhalli sosai.
An buga wannan bazuwar, makafi biyu, ci gaba, binciken shiga tsakani mai sarrafa giciye a cikin mujallar kimiyya ta Nutrition ranar 18 ga Janairu, 2022 [1] kuma an gudanar da shi a Asibitin Jami'ar Sant Joan de Reus a Barcelona.Binciken, wanda Dokta Rosa Walls ya jagoranta, marubucin fiye da takardun kimiyya 150 kuma mai kula da yawancin ilimin digiri, ya ƙunshi masu aikin sa kai na 67 masu aikin sa kai tare da hypercholesterolemia da ƙananan matakan LDL na jini.Kowane ɗan takara ya karɓi 250 MG na ABG + ko placebo na makonni shida, tare da lokacin wanke-wanke na mako uku kafin canzawa.An kuma wajabta batutuwan abinci ban da rage yawan lipid da samfuran antihypertensive.
Sakamakon makonni shida ya nuna cewa tsantsa ABG + ya rage yawan karfin jini na diastolic (DBP) ta matsakaicin 5.85 mmHg.idan aka kwatanta da placebo.An bayyana wannan kyakkyawan halayen musamman a cikin maza.Alberto Espinel, Shugaban Bincike da Ci gaba a Pharmaactive, ya yi bayanin: “Rage hawan jini na diastolic da 5 mmHg kawai.Art.na iya rage haɗarin bugun jini da sauran cututtukan jijiyoyin jini sosai.”
Hawan jini yana shafar kusan kashi ɗaya bisa uku na manya a duniya kuma shine babban haɗarin da za'a iya hanawa ga cututtukan zuciya da cututtukan zuciya.Daga cikin mutane masu shekaru 40 zuwa 89, karuwar hawan jini na diastolic na kowane 10 mm Hg.Art.ya ninka haɗarin da ke tattare da cututtukan zuciya na zuciya da bugun jini.
Wannan shine binciken asibiti na farko da aka gudanar don ABG+, yana ginawa akan sakamako masu ƙarfafawa daga binciken dabbobi biyu na kamfanin da suka gabata.Waɗannan gwaje-gwajen sun nuna tasirin sinadarai na cardioprotective kamar yadda yake da ikon daidaita lipids na jini da kyau da haɓaka aikin jigon jini.
"An dade ana la'akari da tsofaffin tafarnuwa a matsayin abinci mai mahimmanci kuma wani bangare na abincin Asiya, da kuma inganta lafiyar jiki," in ji Aspinell.“Shaidu na zahiri sun nuna fa’idar amfanin baƙar tafarnuwa akan lafiyar zuciya.Duk da haka, girman tasirin ya dogara da adadin da nau'in mahadi da aka tara a lokacin tsufa, da kuma ikon cirewa da kuma riƙe waɗannan mahadi yayin sarrafawa.
Wannan sinadari mai daɗi ana yin ta ne ta al'ada ta hanyar adana dukkan kwararan fitila na sabbin tafarnuwa na Sipaniya cikin zafi da zafi na makonni da yawa.Gangar tafarnuwa tana yin duhu kuma suna ɗaukar laushi mai laushi kamar jelly, suna rasa halayen ɗanɗanon tafarnuwa yayin da suke ƙara zaƙi.A lokacin wannan tsari, kwan fitila mai tsufa yana fuskantar manyan canje-canje na biochemical.Babban mahadi na organosulfur, alliin da allicin, an rage su a cikin sabbin tafarnuwa.Duk da haka, rikitaccen hadadden bioactive na polyphenols masu narkewa (mafi yawa PAA, flavonoids da melanoids) ya haɓaka sosai.Haɗin gwiwar waɗannan antioxidants ana ɗaukar babban tushen ABG+'s cardioprotective Properties.
Pharmaactive ABG + tsantsa an daidaita shi zuwa 1.25 MG S-allyl-L-cysteine (SAC) polyphenols.An kera shi ta amfani da fasahar tsufa na ABG Cool-Tech® na kamfanin.An tabbatar da ƙaddamarwar SAC mai arziƙi ta HPLC (high aikin ruwa chromatography).
"SAA kusan ba ya nan a cikin sabbin tafarnuwa, amma ana haɗa shi kuma ana tarawa lokacin da ya girma a ƙarƙashin wasu yanayin muhalli," in ji Espinel.“Kasancewar da tattara abubuwa masu aiki sun dogara sosai kan tsarin masana'antu.Yawancin kayayyakin tafarnuwa baƙar fata a kasuwa ana amfani da su ne kawai don kayan dafa abinci kuma suna ɗauke da kaɗan ko babu SAC.A wasu lokuta, ana samun SAC daga tafarnuwa ta hanyar dogon tsarin masana'antu wanda ya haɗa da shayar da kwararan fitila a cikin kaushi na kwayoyin halitta, sakamakon kawai ana yiwa lakabi da "tsohuwar tafarnuwa".Wannan yana yin sulhu da abun ciki na bioactive, kuma inda binciken da ake yi a kan tsantsar tafarnuwa baƙar fata ya nuna sakamako masu karo da juna kuma yana haifar da kyakkyawan aiki."
"Wannan ita ce shaida ta farko na daidaitawar tasirin hawan jini na ABG + tsantsa a matsayin madadin halitta ga al'ummomin da dabarun sa baki suka dogara ne akan abinci da kuma kula da salon rayuwa," in ji Espinel."Mahimmanci, ana samun ingantaccen tasirin sa ta hanyar ɗaukar kwamfutar hannu guda ɗaya na ABG + a kowace rana."
"Bincike na asibiti na gaba zai mayar da hankali kan iyawar sarrafa hawan jini na ABG + tsantsa," in ji Julia Diaz, Shugaban Kasuwanci, Pharmaactive.“Zaɓuɓɓukan rayuwa, gami da tsarin abinci irin su DASH ko abincin Bahar Rum, jiyya ce ta farko don rage gudu da hana hawan jini.ABG + wani kayan aiki ne mai inganci kuma mai daɗi don taimakawa wajen sarrafa hawan jini, musamman waɗanda ke da hawan jini.”Daga cikin marasa lafiya da bugun jini.Wadanda ke da wahalar bin ƙuntatawa na abinci."
Duk abubuwan ABG + suna da narkewar ruwa kuma ana iya amfani da su a aikace-aikace iri-iri ciki har da gumi, capsules, gels mai laushi, syrups da foda.Ba tare da ƙamshi da ɗanɗanon tafarnuwa ba, abubuwan ABG + sun dace don abinci mai aiki har ma da ɗanɗano.
Pharmaactive Biotech Products (SLU) wani kamfani ne na fasahar kere kere na majagaba wanda ke zaune a Madrid wanda ke haɓakawa da kera nau'ikan nau'ikan nau'ikan halitta na kimiyya daban-daban kamar tsantsar saffron mai tsafta da tsohuwar tafarnuwa.Manufar kamfanin ita ce yin tasiri mai kyau kuma mai mahimmanci ga lafiyar mutane da jin dadin jama'a ta hanyar amfani da kayan lambu masu inganci, wanda binciken kimiyya ya goyi bayan kuma kwamitin da'a ya amince da shi.Yana girma, noma da kuma samar da albarkatun shuka daga gona zuwa cokali mai yatsa tare da mafi ƙarancin tasirin muhalli.
Tuntuɓar Kamfanin: Pharmaactive Biotech Products, SLU Eva Criado, Mai Gudanar da Hulɗar Jama'a Waya: +34 625 926 940 Email: [email protected] Twitter: @Pharmactive_SPWeb: www.pharmaactive.eu
Tuntuɓar mai jarida: NutriPR Liat Simha Waya: +972-9-9742893 Email: [email protected] Twitter: @NutriPR_Web: www.nutripr.com
Lokacin aikawa: Agusta-21-2023